secwatch.observer — SEC 8-K summary
======================================

Issuer:     CytomX Therapeutics, Inc. (CTMX)
CIK:        0001501989
Form:       8-K
Filed at:   2022-06-21T23:59:59+00:00
Accession:  0001193125-22-177650
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

CytomX shareholders elect McCarthy and Mohindru as directors, ratify E&Y, approve exec comp
--------------------------------------------------------------------------------

- Class I directors Sean McCarthy and Mani Mohindru elected with ~68% of votes cast.
- Ratification of Ernst & Young as auditor for FY2022 passed with 99.95% of votes cast.
- Non-binding advisory vote on named executive officer compensation approved with ~93% support.
- All proposals passed; broker non-votes recorded for directors and say-on-pay only.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1501989/000119312522177650/0001193125-22-177650-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1501989/000119312522177650/d331581d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-177650

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer